: BOARD NOTED MD & CEO P R SESHADRI'S DECISION NOT TO SEEK REAPPOINTMENT AFTER HIS CURRENT TERM ENDS SEPTEMBER 30, 2026, AS HE PURSUES PERSONAL INTERESTS; HE WILL CONTINUE UNTIL THEN.